ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00169156
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : March 13, 2017
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Lymphoma Study Association